Point prevalence survey validation protocol – Version 2.1 - Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals
This protocol is the final ECDC point prevalence survey (PPS) validation protocol, which was adapted according to the findings of the pilot validation study and discussed with experts from Member States at a meeting in London on 5 March 2012. The protocol was implemented in five countries during the final phase of the survey at acute care hospitals in May–June 2012.
In accordance with the Improving Patient Safety in Europe project (IPSE) transition plan and with article II.8.c of Council Recommendation 2009/C 151/01 of 9 June 2009 on patient safety, including the prevention and control of healthcare-associated infections (HAIs), ECDC developed a methodology for carrying out point prevalence surveys (PPSs) of HAIs and antimicrobial use in European acute care hospitals. The main objective of this ECDC PPS is to estimate the total burden of HAI and antimicrobial use in acute care hospitals in the European Union.
In 2011, together with experts from Member States, ECDC developed a pilot validation study protocol to test the feasibility and appropriateness of different methods to assess the validity and reliability of the PPS data. The protocol was implemented at 20 hospitals in 10 of the countries participating in the project ‘Pilot validation study of the ECDC point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals’ (OJ/23/06/2011-PROC/2011/060). The study was outsourced to the Glasgow Caledonian University (Contract ECD.2971) following an Open Call for Tender (OJ/23/06/2011-PROC/2011/060) and coordinated by the Glasgow Caledonian University, in collaboration with Health Protection Scotland (HPS, UK), the Health Protection Agency (HPA, UK), National Institute for Health and Welfare (THL, Finland), French Institute for Public Health Surveillance (InVS, France), Charité - Universitätsmedizin Berlin (Germany) and ECDC.
The current protocol is the final ECDC PPS validation protocol, which was adapted according to the findings of the pilot validation study and discussed with experts from Member States at a meeting in London on 5 March 2012. The protocol was implemented in five countries during the final phase of the first ECDC PPS at acute care hospitals in May–June 2012. The ECDC Advisory Forum recommended that all Member States perform a validation survey during future ECDC PPSs to enable better interpretation of PPS results.
European surveillance of Clostridioides (Clostridium) difficile infections - surveillance protocol version 2.4
17 Dec 2019 - ECDC publishes a protocol developed for the surveillance of Clostridioides (Clostridium) difficile infections (CDI) to address the lack of standardised surveillance of CDI in EU Member States.
Options for national testing and surveillance for hepatitis E virus in the EU/EEA - Operational guidance
5 Sep 2019 - This operational guidance, developed by ECDC in collaboration with its hepatitis E virus (HEV) expert group, offers options on the implementation or adjustment of HEV surveillance at a national level.
Handbook on tuberculosis laboratory diagnostic methods in the European Union - Updated 2018
29 Aug 2018 - This handbook provides network members and other laboratories involved in the diagnosis of tuberculosis, with an agreed list of key diagnostic methods and their protocols in various areas of TB diagnosis.